JP2024545161A5 - - Google Patents
Info
- Publication number
- JP2024545161A5 JP2024545161A5 JP2024534450A JP2024534450A JP2024545161A5 JP 2024545161 A5 JP2024545161 A5 JP 2024545161A5 JP 2024534450 A JP2024534450 A JP 2024534450A JP 2024534450 A JP2024534450 A JP 2024534450A JP 2024545161 A5 JP2024545161 A5 JP 2024545161A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- stapled
- optionally
- antibody
- stapled peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288498P | 2021-12-10 | 2021-12-10 | |
| US63/288,498 | 2021-12-10 | ||
| US202263321968P | 2022-03-21 | 2022-03-21 | |
| US63/321,968 | 2022-03-21 | ||
| US202263353275P | 2022-06-17 | 2022-06-17 | |
| US63/353,275 | 2022-06-17 | ||
| PCT/US2022/052358 WO2023107674A2 (en) | 2021-12-10 | 2022-12-09 | Stapled peptide-antibody conjugates (spacs) and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545161A JP2024545161A (ja) | 2024-12-05 |
| JP2024545161A5 true JP2024545161A5 (enExample) | 2025-12-17 |
Family
ID=86731243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534450A Pending JP2024545161A (ja) | 2021-12-10 | 2022-12-09 | ステープルドペプチド－抗体抱合体（ＳＰＡＣｓ）およびそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4444736A2 (enExample) |
| JP (1) | JP2024545161A (enExample) |
| KR (1) | KR20240125945A (enExample) |
| CN (1) | CN119110805A (enExample) |
| AU (1) | AU2022407066A1 (enExample) |
| CA (1) | CA3238784A1 (enExample) |
| IL (1) | IL312929A (enExample) |
| MX (1) | MX2024007006A (enExample) |
| WO (1) | WO2023107674A2 (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2356139A4 (en) * | 2008-07-23 | 2013-01-09 | Harvard College | LIGURE COMBINED POLYPEPTIDES |
| US11952432B2 (en) * | 2018-02-07 | 2024-04-09 | Dana-Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
-
2022
- 2022-12-09 WO PCT/US2022/052358 patent/WO2023107674A2/en not_active Ceased
- 2022-12-09 AU AU2022407066A patent/AU2022407066A1/en active Pending
- 2022-12-09 CA CA3238784A patent/CA3238784A1/en active Pending
- 2022-12-09 CN CN202280090496.9A patent/CN119110805A/zh active Pending
- 2022-12-09 KR KR1020247023088A patent/KR20240125945A/ko active Pending
- 2022-12-09 EP EP22905164.4A patent/EP4444736A2/en active Pending
- 2022-12-09 JP JP2024534450A patent/JP2024545161A/ja active Pending
- 2022-12-09 MX MX2024007006A patent/MX2024007006A/es unknown
- 2022-12-09 IL IL312929A patent/IL312929A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7553504B2 (ja) | 操作された抗体化合物およびこれらの抱合体 | |
| CN112839683B (zh) | 含有标记部-抗人抗体Fab片段复合物的药物组合物 | |
| JP6585600B2 (ja) | Ｃ末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法 | |
| CN109563128B (zh) | 恶性肿瘤靶向肽 | |
| JP4398644B2 (ja) | ＥｒｂＢ界面ペプチド擬態およびその使用方法 | |
| NZ762376A (en) | Transglutaminase conjugation method and linker | |
| ME02581B (me) | Farmaceutski pripravci s otpornošću na topljivi cea | |
| JPWO2020031936A5 (enExample) | ||
| JP2016516061A5 (enExample) | ||
| JP2015524796A5 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2014506135A5 (enExample) | ||
| AU2021217353A1 (en) | IL-7Rαγc binding compounds | |
| JPWO2020027100A5 (enExample) | ||
| JP2025508009A5 (enExample) | ||
| PL207121B1 (pl) | Związek kahalalidowy, zastosowanie związku, kompozycja farmaceutyczna oraz sposób wytwarzania związku kahalalidowego | |
| JP2024509241A5 (enExample) | ||
| CN104130315A (zh) | 一种特异靶向her2蛋白的多肽 | |
| JP2024513559A5 (enExample) | ||
| CN108047312A (zh) | 一种稳定多肽类蛋白靶向嵌合体分子及其制备方法和用途 | |
| CN105693860B (zh) | 特异性靶向her2蛋白的多肽及其应用 | |
| WO2021163097A1 (en) | Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics | |
| JP2024542192A5 (enExample) | ||
| JP2024545161A5 (enExample) | ||
| MX2011005363A (es) | Peptidos para inhibicion del factor alfa de necrosis tumoral y usos de los mismos. | |
| JP2025513930A5 (enExample) |